Key result
Dihydropyridine calcium channel blockers are effective for hypertension but frequently cause peripheral edema, which may be mitigated by combining them with ACE inhibitors or ARBs.
Why the study?
How can peripheral edema caused by dihydropyridine calcium channel blockers be managed in patients with hypertension?
How can peripheral edema caused by dihydropyridine calcium channel blockers be managed in patients with hypertension?
Combining dihydropyridine calcium channel blockers with ACE inhibitors or ARBs may help alleviate peripheral edema, whereas diuretics are generally ineffective.
No takes yet. Share an insight, caveat, or question.
Edema from dihydropyridine CCBs may compromise BP control; leaves open optimal mitigation strategies in combination regimens.
Marvin Moser (2003) conducted a review in Hypertension. Dihydropyridine calcium channel blockers was evaluated. Dihydropyridine calcium channel blockers are effective for hypertension but frequently cause peripheral edema, which may be mitigated by combining them with ACE inhibitors or ARBs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: